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Increased intracellular reactive oxygen species in patients with these radicals are leakages from the electron transport
end-stage renal failure: Effect of hemodialysis. chains of mitochondria and endoplasmic reticulum. At
Background. Reactive oxygen species (ROS) have been im- low concentrations, ROS act as physiological mediatorsplicated in various forms of cellular injury. ROS may cause
of cellular responses, including activation of lympho-cell damage and are involved in the pathophysiology of several
diseases, including atherosclerosis and chronic inflammation. cytes, whereas higher concentrations may cause cell dam-
Methods. Disturbances of intracellular ROS levels were in- age [1–3]. Increased ROS are thought to be involved in
vestigated in 28 patients with end-stage renal failure. The intra- the pathophysiology of diabetes mellitus, atherosclerosis,cellular ROS levels were measured in lymphocytes before and
hypertension, or chronic inflammatory diseases, includ-after hemodialysis using biocompatible membranes and were
compared with those from 11 patients with end-stage renal ing nephritis [4–7]. ROS have been shown to induce
failure, not yet on renal replacement therapy, and 27 healthy apoptosis in glomerular mesangial cells [8] and vascular
control subjects. ROS levels were measured spectrophotomet- smooth muscle cells [9]. Reduced antioxidative defenserically using the intracellular dye dichlorofluorescin diacetate.
mechanisms, for example, the reduced activity of super-Results. The spontaneous production of ROS was signifi-
cantly higher in lymphocytes from patients with end-stage renal oxide dismutase (SOD), glutathione peroxidase, and cat-
failure compared with healthy control subjects (P , 0.01). alase in erythrocytes, have been described in chronic
The addition of 100 nmol/L phorbol-myristate-acetate (PMA) renal failure [10]. On the other hand, changes of lympho-produced a significant increase of ROS, both in lymphocytes
cyte function have also been detected in chronic renalfrom patients with end-stage renal failure and healthy control
subjects. The PMA-induced ROS increase was significantly failure [11–13].
higher in lymphocytes from patients with end-stage renal fail- There is little evidence that increased oxidative stress
ure compared with healthy control subjects (P , 0.01). In in patients with chronic renal failure is associated withpatients with end-stage renal failure, not yet on renal replace-
uremic complications [14, 15]. In particular, increasedment therapy, the PMA-induced ROS was also significantly
higher compared with healthy control subjects. The PMA- hydroxyl radicals have been associated with uremic hyper-
induced ROS increases were significantly inhibited by catalase, tension [16]. Since lipid peroxidation products, malondi-
but not by superoxide dismutase or the superoxide dismutase
aldehyde and 4-hydroxyalkenals, were found to be in-mimetic, tempol. PMA-induced ROS was significantly reduced
creased in plasma of patients with end-stage renal failureby tyrphostin A51 in lymphocytes from patients with end-stage
renal failure and from healthy control subjects (each P , 0.01), before and after hemodialysis [17], both a weakening of
indicating the involvement of a tyrosine kinase-dependent antioxidant defenses or an increased production of ROS
pathway. In patients with end-stage renal failure, the spontane-
during hemodialysis might be involved in the pathogenesisous and the PMA-induced production of ROS was not signifi-
of the uremic syndrome or in the development of compli-cantly different before and after hemodialysis.
Conclusions. Regular hemodialysis sessions using biocom- cations during long-term hemodialysis treatment.
patible membranes have no effect on the elevated intracellular In contrast to measurements of plasmic lipid peroxida-
ROS in patients with end-stage renal failure.
tion products or the activity of antioxidant enzymes in
erythrocytes, determinations of intracellular ROS may
reflect the cellular oxidative stress more directly. There-Reactive oxygen species (ROS) are byproducts of nor-
fore, in the present study, we investigated the intracellu-mal metabolic processes in cells. The major sources of
lar ROS levels, for example, superoxide radical (O•2) and
hydrogen peroxide (H2O2), in patients with end-stage re-Key words: cell injury, atherosclerosis, inflammation, lymphocytes,
dialysis, renal replacement therapy. nal failure before and after hemodialysis using a fluores-
cent dye technique. It is shown that patients with end-Received for publication August 18, 1999
stage chronic renal failure show increased spontaneousand in revised form January 28, 2000
Accepted for publication March 13, 2000 and stimulated levels of ROS, and intracellular ROS were
not significantly changed during hemodialysis treatment.Ó 2000 by the International Society of Nephrology
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METHODS tion through centrifugation for five minutes at 240 3 g.
The cells were then resuspended in physiological saltPatients
solution ready for use. The physiological salt solution
After giving informed consent, 27 healthy control sub- used throughout this study had the following composi-
jects (9 males and 18 females, mean age of 68 6 5 years, tion (in mmol/L): NaCl 136, KCl 5.4, KH2PO4 0.44,systolic blood pressure 131 6 3 mm Hg, diastolic blood Na2HPO4 0.34, d-glucose 5.6, CaCl2 1.0, MgCl2 1.0, and
pressure 77 6 2 mm Hg) with normal renal function, HEPES 10, pH 7.4.
11 patients with end-stage renal failure (4 males and 7
females, mean age of 65 6 2 years), not yet on renal Measurement of reactive oxygen species
replacement therapy, and 28 stable patients with end- The lymphocytes were incubated in the dark with the
stage renal failure (11 males and 17 females, mean age dye 29,79-dichlorofluorescin diacetate (DCF-DA, 5 mmol/L;
of 72 6 2 years, systolic blood pressure 146 6 4 mm Hg, Calbiochem, Bad Soden, Germany) for 15 minutes prior
diastolic blood pressure 76 6 2 mm Hg), who had been to the measurement of ROS concentrations [21–24].
undergoing maintenance hemodialysis for 22 6 6 months DCF-DA is a nonpolar compound that readily diffuses
(mean 6 SEM), were enrolled in this study. The cause into cells, where it is hydrolyzed to the nonfluorescent
of end-stage renal failure was chronic glomerulonephritis polar derivative DCFH and thereby trapped within the
in 10 cases, diabetic nephropathy in 10 cases, nephroscle- cells [22]. In the presence of ROS, DCFH is oxidized to
rosis in 7 cases, and polycystic kidney disease in 1 case. the highly fluorescent 29,79-dichlorofluorescein (DCF).
All patients were stable and free from intercurrent ill- The level of DCF fluorescence, reflecting the concentra-
ness. As confirmed by the clinical examination and rou- tion of ROS, was monitored using a fluorescence spectro-
photometer (F-2000 Hitachi Ltd., Tokyo, Japan) at 534tine laboratory examination, patients were in a good
nm emission with an excitation wavelength of 488 nm.state of health. All of the patients were routinely dialyzed
To minimize the DCFH, photo-oxidation samples werefor four to five hours three times weekly using bio-
kept in the dark, and the fluorescence was rapidly col-compatible membranes (polysulfone; Fresenius Medical
lected within 60 seconds using identical parameters, suchCare, Bad Homburg, Germany; acrylonitrile and sodium
as bandwidth and brightness, for all samples. Undermethallyl sulfonate copolymer; Hospal, Nu¨rnberg, Ger-
these circumstances, spontaneous photooxidation of themany) with no dialyzer reuse. The dialysates used were
dye was less than 1%. Using H2O2, a calibration curvebicarbonate based. Kt/V values (the amount of plasma
of the DCF fluorescence could be measured. As showncleared of urea divided by the urea distribution volume)
in Figure 1, the DCF fluorescence showed a nonlinearwas measured according to the formula:
increase with increasing H2O2 concentrations.
Kt/V 5 2ln (R 2 0.03) 1 (4 2 3.5 3 R) 3 UF/W Lymphocytes were incubated for 30 minutes with
phorbol-12-myristate-13-acetate (PMA; Sigma Chemicalwhere R is the post-/pre-plasma urea nitrogen ratio; UF
Co., Deisenhofen, Germany). The inactive phorbol esteris the ultrafiltrate volume (L) removed, and W is the
4a-phorbol-12,13-didecanoate (4a-PDD) was used as apostdialysis weight (kg) [18]). Kt/V values were 1.34 6
negative control. Measurements were made in the ab-0.05 (N 5 28). The normalized protein catabolic rate
sence or presence of enzyme inhibitors and scavengers,values [nPCR; measured according to this formula:
2-[8-[(dimethylamino)methyl]-6,7,8,9-tetrahydropyridonPCR 5 C0/(36.3 1 5.48 3 Kt/V 1 53.5/Kt/V) 1 0.168; [1,2-a]indol-3-yl]-3-(1-methylindol-3-yl) maleimide, hydro-using C0 5 pre-plasma urea nitrogen] [19] were 1.01 6 chloride (Ro-32-0432; 140 nmol/L; protein kinase C in-
0.07 g/kg/day (N 5 28). hibitor), 2-Amino-4-(39,49,59-trihydroxyphenyl)-1,1,3-tri-
cyanobuta-1,3-diene (tyrphostin A51; 4 mmol/L; tyrosinePreparation of lymphocytes
kinase inhibitor), SOD (40 mg/mL, superoxide radical
Blood samples were drawn from the antecubital veins scavenger), tempol (membrane-permeable SOD-mimetic;
of healthy control subjects and from the arterial side of Alexis Biochemicals, Gru¨nberg, Germany), and catalase
the arteriovenous fistula of patients with end-stage renal (5 mg/mL, H2O2 scavenger). All substances were freshly
failure. The lymphocytes were isolated from heparinized prepared from stocks for each day’s experiments, and
blood samples according to previously described proce- concentrations given indicate final concentrations after
dure [20]. In brief, the blood was centrifuged at 150 3 g all additions. All substances were purchased from Sigma
for 15 minutes, and the supernatant was removed. The or Calbiochem (La Jolla, CA, USA), if not indicated
blood cells were then diluted with physiological salt solu- otherwise.
tion (1:1), and 5 mL of the mixture were layered on 3
StatisticsmL of lymphoprep (5.6% wt/vol; density 1.077 g/mL;
Nycomed, Oslo, Norway) and then centrifuged for 15 Data are means 6 SEM. Differences were compared
minutes at 240 3 g. The lymphocyte interphase was with the Wilcoxon–Mann–Whitney test or t-test using
the computer software GraphPad Prism 2.0 (GraphPadcarefully aspirated and washed in physiological salt solu-
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Fig. 1. Calibration of 29,79-dichlorofluorescin
(DCF) fluorescence. The calibration curve
shows the increases in DCF fluorescence after
the addition of increasing amounts of H2O2.
The fluorescence excitation was 488 nm (band-
width, 10 nm), and the emission was collected
at 534 nm (bandwidth, 10 nm). Values are the
means from duplicate determinations.
Software, San Diego, CA, USA). Two-tailed values of
P , 0.05 were considered significant.
RESULTS
The spontaneous production of ROS in lymphocytes
was monitored over a period of 30 minutes. Within 30
minutes, ROS increased by 88 6 4% (N 5 27) above the
initial level in unstimulated lymphocytes from healthy
control subjects, whereas ROS increased by 128 6 10%
in lymphocytes from patients with end-stage renal failure
(N 5 28, P , 0.01 compared with healthy control sub-
jects). Two types of biocompatible membranes (polysul-
fone, and acrylonitrile and sodium methylsulfonate co-
Fig. 2. Concentration-response curve of phorbol-myristate-acetate (PMA)-
polymer, AN69) were used for hemodialysis. Therefore, induced production of reactive oxygen species (ROS) in lymphocytes.
The lymphocytes were incubated in the dark with the dye DCF-DAdata were analyzed for possible differences between the
(5 mmol/L) for 15 minutes. The level of DCF fluorescence, reflectingtwo dialyzers. However, the spontaneous production of
the concentration of ROS, was monitored using a fluorescence spectro-
ROS in lymphocytes was not significantly different be- photometer at 534 nm emission with an excitation wavelength of 488
nm. Lymphocytes were stimulated with increasing PMA concentrationstween the two dialyzers (polysulfone, 143 6 17%; AN69,
for 30 minutes. The percentage fluorescence increase above resting115 6 12%, P 5 0.19). In patients with end-stage renal
level within 30 minutes is shown. Data are mean 6 SEM from N 5 3
failure who were not yet on renal replacement therapy, to 5 separate experiments.
the spontaneous production of ROS was not significantly
different compared with healthy control subjects (99 6
15%, N 5 11, vs. 88 6 4%, N 5 27, P 5 0.32).
P , 0.01; Fig. 3). The PMA-induced ROS in lymphocytesLymphocytes were stimulated with the phorbol ester
was not significantly different between the two dialyzersPMA. A concentration response curve is shown in Figure
(polysulfone, 250 6 52%; AN69, 254 6 43%, P 5 0.80).2. PMA dose-dependently induced the production of
In patients with end-stage renal failure, not yet on renalROS, and saturation was reached at a concentration of
replacement therapy, the PMA-induced ROS was sig-100 nmol/L. Additional experiments showed that the
nificantly higher compared with healthy control subjectsinactive phorbol ester 4a-PDD did not induce the pro-
(631 6 149%, N 5 11, vs. 99 6 1%, N 5 27, P , 0.01).duction of ROS in lymphocytes.
The PMA-induced production of ROS was signifi-The PMA (100 nmol/L)-induced production of ROS
cantly reduced in the presence of the H2O2 scavengerwas significantly higher in lymphocytes from patients
catalase (5 mg/mL) both in lymphocytes from patientswith end-stage renal failure compared with healthy con-
trol subjects (252 6 33%, N 5 28, vs. 99 6 1%, N 5 27, with end-stage renal failure (148 6 10%, P , 0.01) and
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In patients with end-stage renal failure, the PMA-
induced production was measured before and after the
hemodialysis session using biocompatible membranes.
The spontaneous ROS production was not significantly
different before and after hemodialysis (128 6 10% vs.
134 6 15%). As indicated in Figure 4, the PMA-induced
ROS production was not significantly different before
and after hemodialysis (252 6 33% vs. 297 6 42%). In
addition, the PMA-induced production was significantly
reduced both before and after hemodialysis in the pres-
ence of the H2O2 scavenger catalase, but not in the pres-
ence of the superoxide radical scavenger SOD. The
PMA-induced production was significantly reduced both
before and after hemodialysis in the presence of the
specific protein kinase C inhibitor Ro-32-0432 and in the
presence of the specific tyrosine kinase inhibitor tyrphos-
tin A51.
Fig. 3. Phorbol-myristate-acetate (PMA) induced production of reac-
DISCUSSIONtive oxygen species (ROS) in lymphocytes from 28 patients with end-
stage renal failure (j) and 27 healthy control subjects (h). The lympho- In the present study, intracellular ROS were measured
cytes were incubated in the dark with the dye DCF-DA (5 mmol/L)
in lymphocytes using the fluorescent dye technique. Infor 15 minutes. The level of DCF fluorescence, reflecting the concentra-
tion of ROS, was monitored using a fluorescence spectrophotometer at lymphocytes from patients with end-stage chronic renal
534 nm emission with an excitation wavelength of 488 nm. Lymphocytes failure, an increased spontaneous and PMA-induced
were stimulated for 30 minutes with 100 nmol/L PMA alone and in the ROS production could be observed. The PMA-inducedpresence of the hydrogen peroxide scavenger catalase (5 mg/mL), the
ROS production was also increased in a group of patientssuperoxide radical scavenger SOD (40 mg/mL), the specific protein
kinase C inhibitor Ro-32-0432 (140 nmol/L), and the specific tyrosine with end-stage renal failure, not yet on renal replacement
kinase inhibitor tyrphostin A51 (4 mmol/L). The percentage of increase therapy, indicating that an increased ROS production isin fluorescence above the resting level within 30 minutes is shown. Data
an effect of uremia rather than a long-term effect of theare mean 6 SEM. ***P , 0.01 compared with healthy control subjects.
11P , 0.01 compared with PMA-induced ROS alone. hemodialysis treatment. The production of ROS is part
of cellular life, and in lymphocytes, ROS production may
be necessary for activation and proliferation [25, 26]. On
the other hand, increased ROS may be harmful to cellsin healthy control subjects (67 6 8%, P , 0.01; Fig. 3).
and cause functional disabilities. In fact, higher ROSOn the other hand, in the presence of the superoxide
concentrations have been shown to cause cell damageradical scavenger SOD (40 mg/mL), the PMA-induced
[2, 3]. The generation of ROS leads to the activation ofproduction of ROS was not significantly changed, neither
protein tyrosine kinases followed by the stimulation ofin lymphocytes from patients with end-stage renal failure
several signaling systems, including mitogen-activated(234 6 29%) nor in healthy control subjects (117 6
protein kinases, nuclear transcription factors, caspases,16%; Fig. 3). In additional experiments, the membrane-
and intracellular calcium concentrations [27, 28]. Im-permeable SOD-mimetic tempol was used. In the pres-
paired lymphocytic function in chronic renal failure hasence of the SOD-mimetic tempol, the PMA-induced
been described earlier [11–13]. The present study indi-ROS production was not significantly reduced in lym-
cates that one mechanism causing impaired lymphocyticphocytes from patients with end-stage renal failure
function in chronic renal failure may be due to an in-(1072 6 278%, N 5 5).
creased ROS production.As expected, the PMA-induced production of ROS
Using specific inhibitors, it could be shown that thewas significantly reduced in the presence of the specific
PMA-induced production of ROS was mediated by a tyro-protein kinase C inhibitor Ro-32-0432 (140 nmol/L),
sine kinase-dependent pathway. These pathways couldboth in lymphocytes from patients with end-stage renal
be observed both in patients with end-stage chronic renalfailure and healthy control subjects (each P , 0.01).
failure and in healthy control subjects. These findingsHowever, the PMA-induced production of ROS was also
support earlier reports on the regulatory effect of tyro-significantly reduced in the presence of a specific tyrosine
sine kinase on production of ROS in other cells [29]. Atkinase inhibitor, tyrphostin A51 (4 mmol/L), both in lym-
present, it is not known whether the increased spontane-phocytes from patients with end-stage renal failure and
ous production of ROS in patients with end-stage chronichealthy control subjects (each P , 0.01; Fig. 3). These
renal failure may be caused by changes of activity of thedata indicate that the PMA-induced ROS production is
mediated by a tyrosine kinase-dependent pathway. tyrosine kinase caused by uremic toxins.
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Fig. 4. PMA-induced production of ROS in
lymphocytes from 28 patients with end-stage
renal failure before and after a hemodialysis
session. The lymphocytes were incubated in
the dark with the dye DCF-DA (5 mmol/L)
for 15 minutes. The level of DCF fluorescence,
reflecting the concentration of ROS, was mon-
itored using a fluorescence spectrophotometer
at 534 nm emission with an excitation wave-
length of 488 nm. Lymphocytes were stimu-
lated for 30 minutes with 100 nmol/L PMA
alone and in the presence of the hydrogen
peroxide scavenger catalase (5 mg/mL), the
superoxide radical scavenger SOD (40 mg/mL),
the specific protein kinase C inhibitor Ro-32–
0432 (140 nmol/L), and the specific tyrosine
kinase inhibitor tyrphostin A51 (4 mmol/L).
The percentage fluorescence increase above
resting level within 30 minutes is shown. Data
are mean 6 SEM. 11P , 0.01 compared with
PMA-induced ROS alone.
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